https://scholars.lib.ntu.edu.tw/handle/123456789/473612
標題: | Ex vivo expanded human Vγ9vδ2 T-cells can suppress epithelial ovarian cancer cell growth | 作者: | Mao T.L. TSUI-LIEN MAO Liao Y.J. Chen Y.J. Yeh C.Y. Liu C.L. |
關鍵字: | NSG mice; Ovarian cancer; Pamidronate (PAM); Vγ9Vδ2-T cells; Xenograft | 公開日期: | 2019 | 出版社: | MDPI AG | 卷: | 20 | 期: | 5 | 起(迄)頁: | 1139 | 來源出版物: | International Journal of Molecular Sciences | 摘要: | γδ-T-cells have attracted attention because of their potent cytotoxicity towards tumors. Most γδ-T-cells become activated via a major histocompatibility complex (MHC)-independent pathway by the interaction of their receptor, Natural Killer Group 2 Member D (NKG2D) with the tumor-specific NKG2D ligands, including MHC class I-related chain A/B (MICA/B) and UL16-binding proteins (ULBPs), to kill tumor cells. However, despite their potent antitumor effects, the treatment protocols specifically targeting ovarian tumors require further improvements. Ovarian cancer is one of the most lethal and challenging female malignancies worldwide because of delayed diagnoses and resistance to traditional chemotherapy. In this study, we successfully enriched and expanded γδ-T-cells up to ~78% from peripheral blood mononuclear cells (PBMCs) with mostly the Vγ9Vδ2-T-cell subtype in the circulation. We showed that expanded γδ-T-cells alone exerted significant cytotoxic activities towards specific epithelial-type OVCAR3 and HTB75 cells, whereas the combination of γδ-T cells and pamidronate (PAM), a kind of aminobisphosphonates (NBPs), showed significantly enhanced cytotoxic activities towards all types of ovarian cancer cells in vitro. Furthermore, in tumor xenografts of immunodeficient NSG mice, γδ-T-cells not only suppressed tumor growth but also completely eradicated preexisting tumors with an initial size of ~5 mm. Thus, we concluded that γδ-T-cells alone possess dramatic cytotoxic activities towards epithelial ovarian cancers both in vitro and in vivo. These results strongly support the potential of clinical immunotherapeutic application of γδ-T-cells to treat this serious female malignancy. ? 2019 by the authors. Licensee MDPI, Basel, Switzerland. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062639386&doi=10.3390%2fijms20051139&partnerID=40&md5=c46e3cce57b1429a2daaf47452c972be https://scholars.lib.ntu.edu.tw/handle/123456789/473612 |
ISSN: | 1661-6596 | DOI: | 10.3390/ijms20051139 | SDG/關鍵字: | gamma interferon; interleukin 2; natural killer cell receptor NKG2D; pamidronic acid; tumor necrosis factor; lymphocyte antigen receptor; antineoplastic activity; apoptosis; Article; cancer growth; cancer immunotherapy; cell adhesion; controlled study; cytotoxicity; enzyme linked immunosorbent assay; female; flow cytometry; gamma delta T lymphocyte; human; human cell; immunohistochemistry; major histocompatibility complex; mouse; MTT assay; natural killer cell; ovarian cancer cell line; ovary carcinoma; scanning electron microscopy; short tandem repeat; tumor microenvironment; tumor volume; upregulation; xenograft; adoptive immunotherapy; animal; cell proliferation; cell survival; coculture; cytology; drug screening; immunology; metabolism; mononuclear cell; ovary tumor; pathology; T lymphocyte; tumor cell line; Animals; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coculture Techniques; Female; Humans; Immunotherapy, Adoptive; Leukocytes, Mononuclear; Mice; Ovarian Neoplasms; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes; Xenograft Model Antitumor Assays |
顯示於: | 病理學科所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。